CAMBRIDGE, Mass.–(BUSINESS WIRE)–$SRPT #CharityCasino—CureDuchenne
In Giving announced they are co-hosting Dealing
for Duchenne in Cambridge on October 20 in the heart of Kendall
Square to help save the lives of those with Duchenne muscular dystrophy.
Cambridge will turn vintage Vegas for a one-of-a-kind night of friendly
competition in poker, blackjack, and other classic casino table games.
This charity casino night will benefit and fund research projects to
help find a cure for Duchenne muscular dystrophy.
Janet Wu, a former Channel 7 news science reporter, will emcee the
evening’s events which will include honoring Dr.
Lou Kunkel of the Harvard Stem Cell Institute. Dr. Kunkel is an
internationally recognized geneticist with years of experience and
scientific success in the understanding of the basis for muscular
dystrophies. Dr. Kunkel is universally recognized for the identification
of the gene and encoded protein, dystrophin, which is mutated in boys
The evening features food, drinks, casino night, prizes, and a live and
silent auction. With DJ J Boom spinning Ocean’s 11 beats, signature
cocktails hand mixed by Andrew Cabot of Privateer Rum, and a Rat Pack
Martini Bar, the night will be a great opportunity to network with
colleagues from VC firms, hedge funds and the Biotech C-suite. Guests
have an opportunity to test ride and win a high end electric car.
“We are pleased to partner with Art in Giving to engage the Cambridge
business community for a fun evening to help raise funds to find much
needed treatments for Duchenne,” said Dr. Jak Knowles, MD, Managing
Director, CureDuchenne Ventures and Vice President of Medical and
Scientific Affairs, CureDuchenne. “Proceeds from this event will be used
to fund projects that accelerate drug development targeting all aspects
of this devastating disease.”
“Art in Giving is dedicated to supporting pediatric cancer research via
the sale of fine art. We understand the impact that rare diseases, like
Duchenne, can have on children and recognize the urgent need to find
solutions for patients suffering from these diseases,” said Salvatore
Zinno, Advisory Board Member, Art in Giving. “We are proud to support
CureDuchenne and partner with them on this event that we believe will
help educate the public about Duchenne, while generating the financial
support needed to find solutions for patients.”
Duchenne muscular dystrophy is a fatal genetic muscle disease that
impacts 300,000 patients worldwide, most of them boys and young men.
Duchenne patients are usually diagnosed at age 5, lose their ability to
walk by 12 and most don’t survive their mid-20s. Currently there is no
cure for Duchenne. Proceeds of the event will fund impactful research to
find a cure for Duchenne.
Dealing for Duchenne – Cambridge sponsors include: Jones Lang LaSalle,
Bridge Bank, Sherin & Lodgen LLP, The Richmond Group, Arrowstreet Inc.,
BioMed Realty, Sarepta Therapeutics, Shire, Mitobridge, Catabasis
Pharmaceuticals, Boston Private Bank, Lee Kennedy Co Inc, Wave Life
Science, Yale Appliance + Lighting, Pfizer, Total Office, Allsteel
Office, Absolute Vodka, 90+ Cellars, Privateer Rum and Parlor Skis.
For more information or to purchase tickets, go to www.dealingfordmd.org
or call 949-872-2552.
CureDuchenne is a national nonprofit organization dedicated to finding a
cure for Duchenne muscular dystrophy, the most common and lethal form of
muscular dystrophy. Duchenne affects more than 300,000 people worldwide,
most of them boys and young men. With the help of CureDuchenne’s
distinguished international panel of Scientific Advisors, funds raised
by CureDuchenne support the most promising research aimed at treating
and curing Duchenne. To date, nine CureDuchenne funded research projects
have advanced into human clinical trials. CureDuchenne also brings
physical therapy and standard of care to local communities around the
country through its CureDuchenne Cares Program. For more information,
please visit CureDuchenne.org and follow us on Facebook,
About Art in Giving
Art in Giving is a nonprofit with a unique business model that generates
funding for pediatric cancer research through the sale and loan of fine
art. Art in Giving combines the ingenuity of childhood cancer
researchers with the creativity of artists. Researchers stretch the
limits of their minds in a relentless pursuit to cure cancer. Artists
stretch the limits of their imagination to appeal to our hearts and
souls. Art in Giving follows a unique path that combines the creativity
and generosity of its artists with the needs of talented cancer
researchers. Up to 50% of the proceeds from the sale of art through the
efforts of Art in Giving are donated to The Rachel Molly Markoff
Foundation. The Foundation is a 501(c)(3) public charity that makes
grants to cancer researchers.